Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer
Clinical trial NCT00876486 · COMPLETED
Trial details
- NCT number
- NCT00876486
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2013-02-01
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.